Campbell & Co. Investment Adviser »

Arrowhead Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 38k 28.60
2022-06-30 $320k 9.1k 35.22
2019-06-30 $389k 15k 26.50
2018-12-31 $148k 11k 13.77

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
FMR
Artal Group
Geode Capital Management
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Credit Suisse
Northern Trust
Rokos Capital Management
Pictet Asset Management Holding SA
Morgan Stanley
venBio Select Advisor
Bank of New York Mellon
Goldman Sachs Group

View all funds holding Arrowhead Pharmaceuticals